George Paul

George Paul

Director Director DIN 01563110
DIN 01563110 First appointment Aug 2005 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2005
Shareholding value β€’β€’β€’β€’ Premium profile

About George Paul

Data last updated:

George Paul was a Director at Dr. B.P. Rajan International Institute Of Medical Sciences (2012–2018) and Whole-Time Director at Salem Biomedical Research Private Limited (from 2005). The companies operate in Healthcare.

DIN 01563110
Primary Designation Director
Industry Healthcare
First Appointment 24 Aug 2005
Oldest Company Age 21 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Jul 20122012Active
Whole-Time Director24 Aug 20052005₹28,666 (FY 2019)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Salem Biomedical Research Private Limited
Dr. B.P. Rajan International Institute Of Medical Sciences
Premium access

Shareholding and investment profile for George Paul

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about George Paul

George Paul was first appointed on 24 Aug 2005 as Whole-Time Director at Salem Biomedical Research Private Limited. The most recent appointment on record is 25 Jul 2012 at Dr. B.P. Rajan International Institute Of Medical Sciences.

George Paul held 2 earlier board appointments: Dr. B.P. Rajan International Institute Of Medical Sciences (Director, 25 Jul 2012 to 01 Aug 2018); Salem Biomedical Research Private Limited (Whole-Time Director, from 24 Aug 2005).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available